Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists
Therapeutic Advances in Respiratory Disease · 2025
DOI: 10.1177/17534666251364056 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2025. Verfasst von Lior Zornitzki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine B, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Palliative Care, Pulmonary Disease, Chronic Obstructive, Heart Failure, Healthcare Disparities. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Palliativpflege, Herzinsuffizienz, COPD
Abstract (Originalsprache)
Background
Palliative care is essential for managing advanced chronic illnesses (ACI) but remains underused.
Objectives
We aimed to evaluate the prevalence, associations, and outcomes of palliative care utilization (PCU) in patients with ACIs.
Design
A prospective observational questionnaire-based study.
Methods
The study included hospitalized patients with severe COPD ( n = 53), advanced heart failure (HF; n = 56), or metastatic malignancy ( n = 57). Participants were interviewed about their demographics, health status, PCU, and end-of-life decision-making.
Results
A total of 166 subjects were included (median age: 77 years; 41% females), with a 1-year median of 2 hospital admissions. Subjects with COPD and HF had low rates of PCU compared to those with malignancy (6% and 11% vs 39%, p < 0.01). PCU occurred exclusively in patients who had visited a specialist (cardiologist, pulmonologist, or oncologist) before study inclusion. Patients with PCU were more aware of advance directives (71% vs 38%), signed advanced orders (23% vs 3%), and shared their end-of-life decisions with others (71% vs 29%). These differences remained significant after adjustment for prior specialist visits. Independent associations with PCU were self-identifying as non-religious (adjusted OR 3.41, 95% CI 1.2–9.9), above high-school education (AOR 2.84, 95% CI 1.1–7.3), and chronic pain (aOR 2.81, 95% CI 1.11–7.14), while COPD showed the opposite (aOR 0.25, 95% CI 0.07–0.96).
Conclusion
Palliative care utilization is alarmingly low among patients with HF and COPD despite significant symptom burden. Specialists should advocate for PCU as their involvement could enhance end-of-life care planning, improve patient outcomes, and address current gaps in care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine B, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
- The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Palliative Care Unit, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Internal Medicine B, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street Tel Aviv 6423906, Tel Aviv, Israel.
ORCID-Profile: Ophir Freund
Zitieren
APA
Zornitzki, L., Sror, N., Bar-Shai, A., Tellem, R., Banai, S., Frydman, S., Bornstein, G., & Freund, O. (2025). Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666251364056
Vancouver
Zornitzki L, Sror N, Bar-Shai A, Tellem R, Banai S, Frydman S, et al. Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists. Therapeutic Advances in Respiratory Disease. 2025. doi:10.1177/17534666251364056
BibTeX
@article{Zornitzki2025,
author = {Zornitzki, Lior and Sror, Neta and Bar-Shai, Amir and Tellem, Rotem and Banai, Shmuel and Frydman, Shir and Bornstein, Gil and Freund, Ophir},
title = {Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2025},
doi = {10.1177/17534666251364056}
}
EUVIMED